-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Dow Jones·04/01/2025 11:00:00

Please log in to view news